New drug timing may boost immune attack on head and neck cancer
Disease control
Recruiting now
This study tests a different way of giving chemotherapy together with the immunotherapy drug pembrolizumab for people with head and neck cancer that has come back or spread. The idea is that giving chemo in short, strong bursts after the immunotherapy might help the immune system…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Apr 29, 2026 03:59 UTC